| 000 | 01414 a2200361 4500 | ||
|---|---|---|---|
| 005 | 20250513141708.0 | ||
| 264 | 0 | _c19980612 | |
| 008 | 199806s 0 0 eng d | ||
| 022 | _a0271-0749 | ||
| 024 | 7 |
_a10.1097/00004714-199804000-00002 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aNair, N P | |
| 245 | 0 | 0 |
_aTherapeutic equivalence of risperidone given once daily and twice daily in patients with schizophrenia. The Risperidone Study Group. _h[electronic resource] |
| 260 |
_bJournal of clinical psychopharmacology _cApr 1998 |
||
| 300 |
_a103-10 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntipsychotic Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aBasal Ganglia Diseases _xchemically induced |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPsychiatric Status Rating Scales |
| 650 | 0 | 4 |
_aRisperidone _xadministration & dosage |
| 650 | 0 | 4 |
_aSchizophrenia _xdrug therapy |
| 650 | 0 | 4 | _aTherapeutic Equivalency |
| 773 | 0 |
_tJournal of clinical psychopharmacology _gvol. 18 _gno. 2 _gp. 103-10 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/00004714-199804000-00002 _zAvailable from publisher's website |
| 999 |
_c9522779 _d9522779 |
||